We are live on
!
Find out more
TEC
Tiger Eye Capital Portfolio holdings
AUM
$113M
1-Year Est. Return
11.44%
This Fund
S&P 500
This Quarter
Est. Return
+1.48%
1 Year Est. Return
-11.44%
3 Year Est. Return
+116.39%
5 Year Est. Return
+328.27%
10 Year Est. Return
–
AUM
$734M
AUM Growth
-$627M
(-46%)
Cap. Flow
-$611M
Cap. Flow
% of AUM
-83.31%
Top 10 Holdings %
Top 10 Hldgs %
54.19%
Holding
58
New
13
Increased
8
Reduced
12
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$34.1M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$32.4M |
| 3 |
Visa
V
|
+$32.1M |
| 4 |
JAH
JARDEN CORPORATION
JAH
|
+$22.9M |
| 5 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$22.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$64.6M |
| 2 |
AGN
Allergan plc
AGN
|
+$55.9M |
| 3 |
Axalta
AXTA
|
+$48M |
| 4 |
Apple
AAPL
|
+$44.7M |
| 5 |
Liberty Global Class A
LBTYA
|
+$43.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 21.58% |
| 2 | Healthcare | 21.31% |
| 3 | Industrials | 18.36% |
| 4 | Communication Services | 16.91% |
| 5 | Technology | 8.01% |
Similar funds
SCA
KWM
NF
PCG
BA
EL
CFN
BRWM
Tiger Eye Capital's Q3 2015 Portfolio in Review
As of Q3 2015, Tiger Eye Capital held 58 positions worth $734M, down 46% from $1.36B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Tiger Eye Capital withdrew a net $611M in Q3 2015, closing 25 positions and reducing 12 holdings. Its most notable exit was Bausch Health, an estimated $64.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Tiger Eye Capital opened a new position in Walgreens Boots Alliance worth $31.3M.
- Tiger Eye Capital's largest Q3 2015 buy was Walgreens Boots Alliance: 376,698 shares worth $31.3M.
- Tiger Eye Capital added most to Envision Healthcare Holdings Inc in Q3 2015, an estimated $22.4M increase.
- Tiger Eye Capital's biggest Q3 2015 reduction was Allergan plc, cutting an estimated $55.9M.
- Tiger Eye Capital fully exited Bausch Health in Q3 2015, selling an estimated $64.6M.
- Tiger Eye Capital's ten largest holdings make up 54% of its $734M portfolio in Q3 2015.
- Tiger Eye Capital opened 13 new positions and closed 25 in Q3 2015.
- Tiger Eye Capital's portfolio value fell 46% quarter-over-quarter to $734M.
Based on Tiger Eye Capital's 13F filing for Q3 2015, filed 10 Nov 2015.